ليست عنوان مقالات لاتين Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting Herbivory responsive C2H2 zinc finger transcription factor protein StZFP2 from potato

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting

2

Hepatitis C infection: a review on epidemiology and management of occupational exposure in health care workers for general physicians working in Iranian health network setting

3

Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function

4

Hepatitis C minimal residual viremia (MRV) detected by TMA at the end of Peg-IFN plus ribavirin therapy predicts post-treatment relapse

5

Hepatitis C NS3 helicase unwinds RNA in leaps and bounds

6

Hepatitis C NS3 protease inhibition by peptidyl-α-ketoamide inhibitors: kinetic mechanism and structure

7

Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives

8

Hepatitis C outbreak astounds Spain

9

Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population

10

Hepatitis C Prevalence and Risk Factors in the Northern Alberta Dialysis Population

11

Hepatitis C Rapid Point-of-Care Testing and Laboratory-based Non-invasive Assessment of Liver Fibrosis among Drug Abusers: An Experience from Iran

12

Hepatitis C seropositivity in patients with acute and chronic urticaria

13

Hepatitis C seroprevalence among intravenous drug users in Tehran

14

Hepatitis C seroprevalence among newly incarcerated inmates in the Texas correctional system

15

Hepatitis C therapy in treatment-naïve patients

16

Hepatitis C transmission associated with intravenous immunoglobulins

17

Hepatitis C transmission by cosmetic tattooing in women

18

Hepatitis C Treatment Among People Who Use Drugs in an Office-Based Opioid Treatment Program Versus a Syringe Exchange Program: A Real-World Prospective Clinical Trial

19

Hepatitis C treatment update

20

Hepatitis C Viral Heterogeneity Based on Core Gene and an Attempt to Design Small Interfering RNA Against Strains Resistant to Interferon in Rawalpindi, Pakistan

21

Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules

22

Hepatitis C viral kinetics in difficult to treat patients receiving high dose interferon and ribavirin

23

Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-α2a/ribavirin therapy

24

Hepatitis C viral life cycle

25

Hepatitis C virus

26

Hepatitis C Virus - Related Hepatocellular Carcinoma in the Era of Direct - Acting Antiviral Agents

27

Hepatitis C Virus (HCV) “A Possible Independent Risk Factor” for Coronary Artery Disease

28

Hepatitis C virus (HCV) E1 and E2 protein regions that specifically bind to HepG2 cells

29

Hepatitis C virus (HCV) genotype 1B infection is associated with a high incidence of graft cirrhosis after liver transplantation (OLT)

30

Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma

31

Hepatitis C virus (HCV) hypervariable region 1 complexity does not correlate with severity of liver disease, HCV type, viral load or duration of infection

32

Hepatitis C virus (HCV) infection in hemodialysis patients in the south of Jordan

33

Hepatitis C virus (HCV) Infection Rate among Seronegative Hemodialysis Patients Screened by Two Methods; HCV Core Antigen and Polymerase Chain Reaction

34

Hepatitis C Virus (HCV) Prevalence in Special Populations and Associated Risk Factors: A Report From a Tertiary Hospital

35

Hepatitis C virus (HCV) status in newborns born to HCV positive women performing intracytoplasmic sperm injection

36

Hepatitis C virus (HCV)-driven stimulation of subfamily-restricted natural IgM antibodies in mixed cryoglobulinemia

37

Hepatitis C virus (HCV)-infection and oral lichen planus

38

Hepatitis C Virus and Associated Risk Factors among Prison Inmates with History of Drug Injection in Isfahan, Iran

39

Hepatitis C virus and blood transfusion: past and present risks

40

Hepatitis C virus and hepatocellular carcinoma

41

Hepatitis c virus and human immunodeficiency virus: clinical issues in coinfection

42

Hepatitis C Virus and Human Immunodeficiency Virus-I (HIV) Co-Infection in Children in Benin City, Nigeria.

43

Hepatitis C virus and kidney disease

44

Hepatitis C Virus and Lichen Planus: The Real Association

45

Hepatitis C virus and liver steatosis: when fat is not beautiful

46

Hepatitis C Virus and Vaccine Development

47

Hepatitis C Virus Antibodies and Vitiligo Disease

48

Hepatitis C Virus Antibody Positive Cases in Multitransfused Thalassemic Patients in South of Iran

49

Hepatitis C virus antibody, viral RNA and genotypes in leprous patients in Japan

50

Hepatitis C Virus as a Multifaceted Disease: A Simple and Updated Approach for Extrahepatic Manifestations of Hepatitis C Virus Infection

51

Hepatitis C virus assembly: When fat makes it easier

52

Hepatitis C Virus Capsid Protein and Intracellular Lipids Interplay and Its Association With Hepatic Steatosis

53

Hepatitis C virus challenges AIDS associated viruses at the transfusion crossings: the place and time for a second trial

54

Hepatitis C virus clearance improves quality of life

55

Hepatitis C virus Core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin

56

Hepatitis C Virus Core Antigen as an Alternative to RNA in the Assessment of Response to Treatment with Direct-acting Oral Antivirals

57

Hepatitis C virus core protein downregulates E-cadherin expression via activation of DNA methyltransferase 1 and 3b

58

Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression

59

Hepatitis C virus core protein impairs in vitro priming of specific T cell responses by dendritic cells and hepatocytes

60

Hepatitis C virus core protein inhibits human immunodeficiency virus type 1 replication

61

Hepatitis C virus Core protein overcomes all-trans retinoic acid-induced cell growth arrest by inhibiting retinoic acid receptor-β2 expression via DNA methylation

62

Hepatitis C virus Core protein overcomes stress-induced premature senescence by down-regulating p16 expression via DNA methylation

63

Hepatitis C virus core protein potentiates c-Jun N-terminal kinase activation through a signaling complex involving TRADD and TRAF2

64

Hepatitis C virus Core protein stimulates cell growth by down-regulating p16 expression via DNA methylation

65

Hepatitis C Virus Core Protein: An Update on Its Molecular Biology, Cellular Functions and Clinical Implications

66

Hepatitis C Virus Cryoglobulinemia and non-Hodgkin Lymphoma

67

Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients

68

Hepatitis C virus E2 links soluble human CD81 and SR-B1 protein

69

Hepatitis C virus eradication associated with hepatitis B virus superinfection and development of a hepatitis B virus specific T cell response

70

Hepatitis C virus genetic variability in patients undergoing antiviral therapy

71

Hepatitis C virus genotype 1 associated with massive steatosis of the liver and hypo-β-lipoproteinemia

72

Hepatitis C Virus Genotype Distribution in Shiraz, Southern Iran

73

Hepatitis C Virus Genotypes and Association With Viral Load in Yazd, Central Province of Iran

74

Hepatitis C virus genotypes and quasispecies

75

Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia

76

HEPATITIS C VIRUS GENOTYPES IN A NORTHEASTERN AREA OF BRAZIL

77

Hepatitis C virus genotypes in Adana and Antakya regions of Turkey

78

HEPATITIS C VIRUS GENOTYPES IN BAHAWALPUR

79

Hepatitis C virus genotypes in elderly patients with chronic hepatitis C

80

HEPATITIS C VIRUS GENOTYPES IN IRAQ

81

Hepatitis C Virus Genotypes in Patients Referred to Educational Hospitals in Zahedan (2009 ‒ 2013)

82

Hepatitis C virus Genotypes in Patients with End-Stage Renal Disease in East Azerbaijan, Iran

83

Hepatitis C virus genotyping by means of 5′-UR/core line probe assays and molecular analysis of untypeable samples

84

Hepatitis C Virus Genotyping by Melting Curve Analysis in West Azerbaijan, Northwest of Iran

85

Hepatitis C virus in blood donation

86

Hepatitis C virus in breast milk

87

Hepatitis C virus in elderly patients with chronic liver diseases

88

HEPATITIS C VIRUS IN IRAN: EPIDEMIOLOGY OF AN EMERGING INFECTION

89

Hepatitis C virus in Iran; transmission routes, growth in 3a genotype distribution, and lack of liver marker relation with genotypes

90

Hepatitis C Virus in North Africa: An Emerging Threat

91

Hepatitis C virus in people with HIV infection

92

Hepatitis C virus in people with HIV infection

93

Hepatitis C virus in saliva of haemophiliac patients attending an oral surgery unit

94

Hepatitis C virus induced hypobetalipoproteinemia: a possible mechanism for steatosis in chronic hepatitis C

95

Hepatitis C virus infection affects the brain—evidence from psychometric studies and magnetic resonance spectroscopy

96

Hepatitis C virus infection among institutionalised psychiatric patients: a regression analysis of indicators of risk

97

Hepatitis C virus infection among multi-transfused patients and personnel in haemodialysis units in central Islamic Republic of Iran

98

Hepatitis C virus infection among paediatric patients attending University of Assiut Hospital, Egypt

99

Hepatitis C virus infection among patients on hemodialysis: A report from a single center in Iran

100

Hepatitis C Virus Infection among Teaching Hospital Patients in Kano, Nigeria: A Retrospective Study

101

Hepatitis C virus infection and alanine transaminase levels in the general population: a survey in a southern Italian town

102

Hepatitis C virus infection and autoimmune thrombocytopenic purpura

103

Hepatitis C Virus Infection and Chronic Obstructive Pulmonary Disease

104

Hepatitis C virus infection and cryoglobulinemia

105

Hepatitis C virus infection and genotypes in blood donors

106

Hepatitis C Virus Infection and HCV Genotypes of Hemodialysis Patients

107

Hepatitis C Virus Infection and Kidney Transplantation A Review for Clinicians

108

Hepatitis C virus infection and lymphoproliferative diseases: Prospective study on 1,576 patients in France

109

Hepatitis C virus infection and primary Sjögrenʹs Syndrome: A clinical and serologic description of 9 patients

110

Hepatitis C virus infection and risk factors in health-care workers at Ain Shams University Hospitals, Cairo, Egypt

111

Hepatitis C Virus Infection Complicated by Kidney Disease

112

Hepatitis C Virus Infection in Blood Donors: An Emerging Risk to Transfusion Services

113

Hepatitis C virus infection in children

114

Hepatitis C virus infection in dialysis centers of Tabriz, Iran: a multicenter study

115

Hepatitis C virus infection in dialysis patients

116

Hepatitis C virus infection in Eastern Europe

117

Hepatitis C virus infection in hemodialysis patients in Sudan: Two centers report

118

Hepatitis C Virus Infection in Iran; Viral Spread Routes in General Population and Safety Measures

119

Hepatitis C Virus Infection in Isfahan, Iran: A Review Article

120

Hepatitis C virus infection in nephrology patients

121

Hepatitis C Virus Infection in Non-Hodgkin’s Lymphoma: A Case-ControlStudy

122

HEPATITIS C VIRUS INFECTION IN PATIENTS ON LONG TERM HEMODIALYSIS

123

Hepatitis C Virus Infection in Patients with Hemophilia in Isfahan, Iran

124

Hepatitis C virus infection in renal transplant recipients: epidemiology, clinical impact, serological confirmation and viral replication

125

Hepatitis C virus infection in special groups

126

Hepatitis C virus infection in the development of hepatocellular carcinoma in cirrhosis

127

Hepatitis C virus infection in the United States

128

Hepatitis C virus infection in Western Europe

129

Hepatitis C virus infection manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis

130

Hepatitis C virus infection of salivary gland epithelial cells : Lack of evidence

131

Hepatitis C Virus Infection Trends in Italy

132

Hepatitis C Virus Infection Trends in Italy, 1996–2006

133

Hepatitis C virus infection, alpha interferon therapy and thyroid dysfunction

134

Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: Targeting the infectious trigger, the autoimmune response, or both?

135

Hepatitis C virus infection, tuberculosis, and sexually transmitted diseases

136

Hepatitis C virus infection: co-infection with HIV and HBV

137

Hepatitis C virus infection: Epidemiology, risk factors and prevention strategies in public health in I.R. IRAN

138

Hepatitis C virus infection: quality of life and side effects of treatment

139

Hepatitis C virus infection: when silence is deception

140

Hepatitis C virus infection-associated non-cryoglobulinaemic monoclonal IgMκ gammopathy responsive to interferon-α treatment

141

Hepatitis C Virus Load in Seropositive Liver and Kidney Transplant Recipients by Quantitative Real-Time PCR Before and After Transplantation

142

Hepatitis C virus molecular clones and their replication capacity in vivo and in cell culture

143

Hepatitis C virus NS3 NTPase/Helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step

144

Hepatitis C virus NS3 protease inhibitors comprising a novel aromatic P1 moiety Original Research Article

145

Hepatitis C Virus NS3 Protease Requires Its NS4A Cofactor Peptide for Optimal Binding of a Boronic Acid Inhibitor as Shown by NMR Original Research Article

146

Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding

147

Hepatitis C virus NS3-4A serine protease inhibitors: SAR of moiety with improved potency

148

Hepatitis C virus NS3-4A serine protease inhibitors: SAR of new P1 derivatives of SCH 503034

149

Hepatitis C virus NS3-4A serine protease inhibitors: Use of a P2–P1 cyclopropyl alanine combination for improved potency

150

Hepatitis C virus NS5A protein protects against TNF-α mediated apoptotic cell death

151

Hepatitis C Virus NS5B Sequence-Based Genotyping Analysis of Patients From the Sharkia Governorate, Egypt

152

Hepatitis C Virus RNA (HCV-RNA) in Blood Donors and Family Members Seropositive for Anti-HCV Antibodies

153

Hepatitis C virus RNA: Dinucleotide frequencies and cleavage by RNase L

154

Hepatitis C virus RNAs replicating in cell culture

155

Hepatitis C Virus Screening of High-Risk Patients in a Canadian Emergency Department

156

Hepatitis C virus seropositivity, but not hepatitis B virus carrier or seropositivity, associated with increased pulse wave velocity

157

Hepatitis C Virus Seroprevalence and Associated Risk Factors Among Male Drug Injectors in Kermanshah, Iran

158

Hepatitis C Virus Subtype 3a Envelope Protein 1 Binding with Human Leukocyte Antigen Class I Types of Pakistani Population: Candidate Epitopes for Synthetic Peptide Vaccine

159

Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report

160

Hepatitis C Virus Subtype 6a Infection in an Iranian Patient: A Case Report

161

Hepatitis C virus transmission by a blood donation negative in nucleic acid amplification tests for viral RNA

162

Hepatitis C virus transmission by intravenous immunoglobulin

163

Hepatitis C virus transmission by monoclonal- purified viral-attenuated factor VIII concentrate

164

Hepatitis C Virus Treatment Revolution: Eastern European Story

165

Hepatitis C Virus Treatment with Sofosbuvir Plus Ribavirin Regimen in Khuzestan Province

166

Hepatitis C virus types 7, 8 and 9 should be classified as type 6 subtypes

167

Hepatitis C virus ultrastructure and morphogenesis.

168

Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV–HCV co-infected patients

169

Hepatitis C virus, rheumatoid factors, and disease progression

170

Hepatitis C virus, Sjögrenʹs syndrome and B-cell lymphoma: linking infection, autoimmunity and cancer

171

Hepatitis C Virus. Current Studies in Hematology and Blood Transfusion : Edited by Harvey Reesink, 212, S. Karger AG, Basel, DM 290, ISBN 3-8055-5866-X

172

Hepatitis C Virus: The Rising Concerns and Growing Hopes, Report From the HCV Symposium, Fourth Tehran Hepatitis Congress, November 2011, Tehran, Iran

173

Hepatitis C Virus; Its Implication for Endodontists

174

Hepatitis C virus-related arthritis

175

Hepatitis C virus-specific B cell activation: IgG and IgM detection in acute and chronic hepatitis C

176

Hepatitis c virus-specific cytolytic t cell responses after antiviral therapy

177

Hepatitis C Virus-Specific DNA Sequences in Human DNA: Differentiation by Means of Restriction Enzyme Analysis at the DNA Level in Healthy, Anti-HCV-Negative Individuals

178

Hepatitis C virus-specific reactivity of CD4+-lymphocytes in children born from HCV-infected women

179

Hepatitis C with and without dermatological manifestations: comparison of human leukocyte antigen-DR types, circulating T-cell subsets, and relation to disease severity

180

181

Hepatitis C, depressive symptoms, viral load, and therapy: interactions and reactions

182

Hepatitis C. Biomedical Research Reports: T. Jake Liang and Jay H. Hoofnagle (Eds.), Academic Press, 2000, ISBN 0-12-447870-0, $99.95

183

HEPATITIS C: A COMMON BUT INFREQUENTLY TREATED DISEASE

184

HEPATITIS C: A LEADING CAUSE OF CIRRHOSIS AT DHQ HOSPITAL D.I.KHAN

185

Hepatitis C: molecular virology and antiviral targets

186

Hepatitis C: prevalence and common genotypes among ethnic groups in Jeddah, Saudi Arabia

187

Hepatitis C: public health strategies

188

Hepatitis C: the clinical spectrum of the disease

189

Hepatitis C: the dermatologic profile

190

Hepatitis C-Associated Chronic Lymphoproliferative Disorders: A Single Center Experience

191

Hepatitis C-Associated Osteosclerosis After Blood Transfusion

192

Hepatitis C-Associated Osteosclerosis: An Unusual Syndrome of Acquired Osteosclerosis in Adults

193

Hepatitis C—virology and future antiviral targets

194

Hepatitis D and B virus genotypes in chronically infected patients from the Eastern Amazon Basin

195

Hepatitis D in Chronic Active Hepatitis B: Prevalence, Liver Enzyme levels and Histopathology-an Epidemiological Study in Shiraz, Southern Iran, 2003-2004

196

Hepatitis D Is a Forgotten Problem in Hemodialysis Patients in the World

197

Hepatitis D Virus Infection Among Hepatitis B Surface Antigen Carriers and in “Isolated anti-HBc” Antibodies Profile in Central Tunisia

198

Hepatitis D virus infection in Isfahan, central Iran: Prevalence and risk factors among chronic HBV infection cases

199

Hepatitis D virus infection in Kermanshah, west of Iran: seroprevalence and viremic infections

200

Hepatitis delta genotypes in chronic delta infection in the northeast of Spain (Catalonia)

201

Hepatitis disease diagnosis using a new hybrid system based on feature selection (FS) and artificial immune recognition system with fuzzy resource allocation

202

Hepatitis DVirus Infection among HIV-HBV Co-Infected Patients in Kermanshah, West of Iran

203

Hepatitis E antibodies and HIV status

204

Hepatitis E associated with surgical training on pigs

205

Hepatitis E in Brazil

206

HEPATITIS E SEROCONVERSION IN UNITED STATES TRAVELERS ABROAD

207

Hepatitis E Virus

208

Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death

209

Hepatitis E virus and HIV infection in homosexual men

210

Hepatitis E virus and pigs: A zoonotic risk in Europe?

211

Hepatitis E Virus and Renal Transplantation

212

Hepatitis E virus and serum level aminotransferases in blood donors

213

Hepatitis E Virus Circulation in Italy: Phylogenetic and Evolutionary Analysis

214

Hepatitis E virus genotyping based on full-length genome and partial genomic regions

215

Hepatitis E virus in Nepal: similarities with the Burmese and Indian variants

216

Hepatitis E virus infection

217

Hepatitis E Virus Infection Among Chronic Hemodialysis

218

Hepatitis E Virus Infection Among Iranian Patients with Beta-Thalassemia

219

Hepatitis E virus infection in a cohort of patients with acute non-A, non-B hepatitis

220

Hepatitis E Virus Infection in a Northern Mexican City: A Cross-Sectional Seroprevalence Study

221

Hepatitis E Virus Infection in Hemodialysis Patients: A Seroepidemiological Survey in Jahrom, Southern Iran

222

Hepatitis E Virus Infection in Iranian Kidney-Transplant Patients

223

Hepatitis E Virus Infection in Macaca Mulatta

224

Hepatitis E Virus Infection: A Neglected Problem in Our Region

225

Hepatitis E virus load in swine organs and tissues at slaughterhouse determined by real-time RT-PCR

226

Hepatitis E Virus Seroprevalence Among Blood Donors in Bushehr, South of Iran

227

Hepatitis E Virus Seroprevalence Among Liver Transplant Recipients with Persistent Elevation of Liver Enzymes: A Single Center Report

228

Hepatitis E Virus Seroprevalence and Viremia in Hemodialysis and HIV Infected Patients in Iran

229

Hepatitis E virus seroprevalence in haemodialysis patients in Zanjan province, Islamic Republic of Iran

230

Hepatitis E virus seroprevalence in HIV positive individuals in Shiraz, Southern Iran

231

Hepatitis E virus: complete genome sequence and phylogenetic analysis of a Nepali isolate

232

Hepatitis E: a virus in waiting

233

Hepatitis E: An emerging awareness of an old disease

234

Hepatitis E: Risk and Prevention

235

Hepatitis G viral RNA in Italian haemophiliacs with and without hepatitis C infection

236

Hepatitis G virus and fulminant hepatic failure: evidence for transfusion-related infection

237

Hepatitis G virus exposure in dialysis patients and blood donors in Isfahan‑Iran

238

Hepatitis G virus in immunosuppressed paediatric allograft recipients

239

Hepatitis G virus in India

240

Hepatitis G virus in Karachi, Pakistan

241

Hepatitis G virus in long-term survivors of haematological malignancy

242

Hepatitis G virus infection

243

Hepatitis G virus infection

244

Hepatitis G virus infection in chronic hepatitis C: frequency, features and response to interferon therapy

245

Hepatitis G Virus Infection in Iranian Blood Donors and High-Risk Groups

246

Hepatitis G-associated aplastic anaemia

247

Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany

248

Hepatitis in Ontario linked to EEG electrodes

249

Hepatitis induced by Kava (Piper methysticum rhizoma)

250

Hepatitis meeting suggests end of “carrier” status

251

Hepatitis Monthly, an International Journal in the Field of Hepatology

252

Hepatitis patients lost to follow-up at a liver centre in a tertiary care hospital of Karachi, Pakistan — a cross-sectional descriptive study

253

Hepatitis treatment in developing countries

254

Hepatitis treatment moves on

255

Hepatitis viral status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma

256

Hepatitis virus infection and atherosclerosis: reply to Vassalle, Zucchelli and Giustini

257

Hepatitis Virus Infection and Hodgkin s Lymphoma: A Review of the Literature

258

Hepatitis virus infections in heart transplant recipients

259

Hepatitis viruses and human immunodeficiency virus co-infection: pathogenisis and treatment

260

Hepatitis viruses and the MAPK pathway: is this a survival strategy?

261

Hepatitis Viruses B and D and Human Immunodeficiency Virus Infections in Hemodialysis Patients in the South of Iran: Prevalence and Genotypes

262

Hepatitis viruses in the XXI century

263

Hepatitis: A Rapidly Spreading Viral Infection in Pakistan

264

Hepatitis-B vaccine down under

265

Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation

266

Hepatitis-C and Hepatitis-B Co-Infections in Patients with Human Immunodeficiency Virus in Tehran, Iran

267

Hepatitis-C Infection Incidence Among the non-Hodgkin’s B-cell Lymphoma Patients in the Northeast of Iran

268

Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study

269

Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study

270

Hepatitis-C virus infection among injecting drug users in Lahore, Pakistan: A cross sectional study

271

Hepatitis-C-virus risk from Italian fertility centre

272

Hepatitis-E-associated fulminant hepatic failure in non-pregnant young women

273

Hepato- and Reno-Protective Impacts of Plantago major: An Experimental Model of Testicular Ischemia/Reperfusion

274

Hepato Protective and Antioxidant Role of Berberis tinctoria Lesch Leaves on Paracetamol Induced Hepatic Damage in Rats

275

Hepatoadrenal syndrome in Egyptian children with liver cirrhosis with and without sepsis

276

Hepatoatrial anastomosis and tricuspid valve replacement in budd-chiari syndrome 8.

277

Hepatobiliary and extra-hepatic malignancies in primary sclerosing cholangitis

278

Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study

279

Hepatobiliary Complications of Sickle Cell Disease among Children Admitted to Al Wahda Teaching Hospital, Aden, Yemen

280

Hepatobiliary Cystadenoma Mimicking Liver Hydatid Cyst

281

Hepatobiliary Cystadenoma with Mesenchymal Stroma Mistaken for Common Bile Duct Stone

282

Hepatobiliary excretion and brain distribution of caffeine in rats using microdialysis Original Research Article

283

Hepatobiliary excretion of 99mTc-EC: A potential source of mistake in the interpretation of renal scintigraphy

284

Hepatobiliary Excretion of Dipyrrinone Sulfonates in Mrp2-Deficient (TR−) Rats

285

Hepatobiliary Fascioliasis: Clinical and Radiological Features

286

Hepatobiliary Involvement in Neonates With COVID-19 Infection: A Narrative Review

287

Hepatobiliary organic anion transporters are differentially regulated in acute toxic liver injury induced by carbon tetrachloride

288

Hepatobiliary scintigraphy: An effective tool in the management of bile leak following laparoscopic cholecystectomy

289

Hepatobiliary surgeons meet immunologists: the case of colorectal liver metastases patients

290

Hepatobiliary surgery

291

HepatoBiliary Surgery and Nutrition - Message from the Editor-in-Chief

292

Hepatobiliary Surgery and Nutrition is indexed by SCIE: a tremendous step forward

293

Hepatobiliary surgery: the past, present, and future learned from Professor Henri Bismuth

294

Hepatobiliary transport

295

Hepatobiliary, renal and bone complications of intestinal failure

296

Hepatoblastoma in a 2-year-old child of a liver-transplanted mother

297

Hepatoblastoma in a patient with a partial trisomy 9p syndrome: a case report

298

Hepatoblastoma Related Tumor Thrombosis Extended to IVC, Ra and Pulmonary Artery Branches: A Case Report

299

Hepatoblastomas in Oman

300

Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene

301

Hepatocarcinogenesis: A polygenic model of inherited predisposition to cancer

302

Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise

303

Hépatocarcinome traité par chémoembolisation et irradiation de haute dose: l’expérience lyonnaise

304

Hepatocellular adenoma displaying a HNF1α inactivation in a patient with familial adenomatous polyposis coli

305

Hepatocellular adenomas in patients taking danazol for here ditary angiooedema

306

Hepatocellular Cancer: A Guide for the Internist

307

Hepatocellular carcinoma

308

Hepatocellular carcinoma

309

Hepatocellular carcinoma

310

Hepatocellular carcinoma

311

Hepatocellular carcinoma

312

Hepatocellular carcinoma

313

Hepatocellular carcinoma

314

Hepatocellular carcinoma

315

Hepatocellular carcinoma (HCC) recurrence and what to do when it happens

316

Hepatocellular carcinoma after radiofrequency ablation therapy: Dynamic CT evaluation of treatment

317

Hepatocellular carcinoma after treatment with cyproterone acetate combined with ethinyloestradiol

318

Hepatocellular Carcinoma and Academic Skills Workshop cosponsored by Hepatobiliary Surgery and Nutrition and AME Publishing Company

319

Hepatocellular carcinoma and extrahepatic primary malignancy

320

Hepatocellular Carcinoma and Its Precursors in 103 HBV-Related Cirrhotic Explanted Livers: A Study from South Iran

321

Hepatocellular carcinoma and the art of prognostication

322

Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?

323

Hepatocellular carcinoma development in cirrhosis

324

Hepatocellular Carcinoma Diagnosis Based on Ultrasound Images Using Feature Selection Techniques and K-nearest Neighbor Classifier

325

Hepatocellular carcinoma from diagnosis to treatment: 15 years of challenges and modification of resection strategies

326

Hepatocellular Carcinoma in a Boy with Progressive familial Intrahepatic Cholestasis Type II: Challenging Identification: Case report

327

Hepatocellular Carcinoma in a non-B non-C Non-alcoholic Steatohepatitis (NBNC-NASH HCC)

328

Hepatocellular carcinoma in a pregnant woman detected by routine screening of maternal α-fetoprotein

329

Hepatocellular carcinoma in a young survivor of major burns

330

Hepatocellular carcinoma in alcoholics

331

Hepatocellular Carcinoma in Dog – Case Report

332

HEPATOCELLULAR CARCINOMA IN EGYPTIANS WITH AND WITHOUT A HISTORY OF HEPATITIS B VIRUS INFECTION: ASSOCIATION WITH HEPATITIS C VIRUS (HCV) INFECTION BUT NOT WITH HCV RNA LEVEL

333

Hepatocellular Carcinoma in Explanted Livers of Patients with Genotype D HBV Cirrhosis: Report of the First Experience from Iran

334

Hepatocellular Carcinoma in Pakistan: Where do We Stand?

335

Hepatocellular carcinoma in patients suffering from primary sclerosing cholangitis

336

Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors

337

Hepatocellular carcinoma in patients with HCV

338

Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis

339

Hepatocellular Carcinoma in Port Harcourt, Nigeria: Clinicopathologic Study of 75 Cases

340

Hepatocellular Carcinoma in Pregnancy with Unusual Presentations

341

Hepatocellular Carcinoma in Sheep.

342

Hepatocellular Carcinoma in Sheep.

343

Hepatocellular carcinoma in situs inversus totalis-a case report

344

Hepatocellular Carcinoma in the World and the Middle East

345

Hepatocellular Carcinoma in Two Patients with Autoimmune Hepatitis, A Single Center Experience and Review of the Literature

346

Hepatocellular Carcinoma is an Emerging Issue Now in Iran

347

Hepatocellular carcinoma markers in the omics era: the glycomic analysis

348

Hepatocellular carcinoma on the increase in USA

349

Hepatocellular carcinoma with disseminated skeletal muscle metastasis

350

Hepatocellular carcinoma with extension into the right atrium

351

Hepatocellular Carcinoma With Intracavitary Cardiac Involvement: A Case Report and Review of the Literature

352

Hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation

353

Hepatocellular carcinoma with progenitor cell features distinguishable by the hepatic stem/progenitor cell marker NCAM

354

Hepatocellular carcinoma with sarcomatous change arising after eradication of HCV via interferon therapy

355

Hepatocellular carcinoma without cirrhosis in the West: epidemiological factors and histopathology of the non-tumorous liver

356

Hepatocellular Carcinoma: A Pledge for Evidence-based Medicine

357

Hepatocellular carcinoma: an entity needed to be differentiated

358

Hepatocellular Carcinoma: An Uncommon Metastasis in the Orbit

359

Hepatocellular Carcinoma: An Update

360

Hepatocellular carcinoma: beyond screening

361

Hepatocellular carcinoma: conventional MRI findings including gadolinium-enhanced dynamic imaging. Review

362

Hepatocellular Carcinoma: First Manifestation as SolitaryHumeral Bone Metastasis

363

Hepatocellular Carcinoma: From Molecular Basis to Novel Treatment Approaches

364

Hepatocellular carcinoma: present status and future prospects

365

Hepatocellular carcinoma-associated fibroblasts trigger NK cell dysfunction via PGE2 and IDO

366

Hepatocellular Damage and Severity of COVID-19 Infection in Iraqi Patients: A Biochemical Study

367

Hepatocellular Expression of SIRT1 and Its Effect on Hepatocellular Carcinoma Progression: A Future Therapeutic Perspective

368

Hepatocellular functions of human liver cells in oxygen-permeable membrane device Original Research Article

369

Hepatocellular lesions with increased iron uptake on superparamagnetic iron oxide-enhanced magnetic resonance imaging in cirrhosis or chronic hepatitis: comparison of four magnetic resonance sequences for lesion conspicuity

370

Hepatocellular oxidative DNA injury induced by macrophage-derived nitric oxide

371

Hepatocellular oxidative stress and initial graft injury in human liver transplantation

372

Hepatocellular proliferation in patients with chronic hepatitis C and persistently normal or abnormal aminotransferase levels

373

Hepatocellular protection by nitric oxide or nitrite in ischemia and reperfusion injury

374

Hepatocellular recurrence after orthotopic liver transplantation: Is combination of α-fetoprotein and glypican-3 a reliable marker?

375

Hepatocellular sulfobromophthalein uptake at physiologic albumin concentrations: kinetic evidence for a high affinity/low capacity sinusoidal membrane system

376

HepatoConsult: a knowledge-based second opinion and documentation system

377

Hepatocurative activity of biosynthesized silver nanoparticles fabricated using Andrographis paniculata

378

Hepatocyte adhesion, growth and differentiated function on RGD-containing proteins

379

Hepatocyte and Islet Cell Cotransplantation on Poly-L-Lactide Matrix for the Treatment of Liver Cirrhosis

380

Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis

381

Hepatocyte behavior on synthetic glycopolymer matrix: inhibitory effect of receptor–ligand binding on hepatocyte spreading

382

Hepatocyte culture on carbohydrate-modified star polyethylene oxide hydrogels

383

Hepatocyte growth factor (HGF) adsorption kinetics and enhancement of osteoblast differentiation on hydroxyapatite surfaces

384

Hepatocyte growth factor (HGF)-induced activation of the AP-1 complex : a comparison between normal and transformed rat hepatocytes

385

Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis

386

Hepatocyte growth factor activates the AP-1 complex: a comparison between normal and transformed rat hepatocytes

387

Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer

388

Hepatocyte growth factor and its actions in growth plate chondrocytes

389

Hepatocyte growth factor and placental development

390

Hepatocyte growth factor as a potential predictor of the presence of atherosclerotic aorto-iliac artery disease

391

Hepatocyte Growth Factor Attenuates the Severity of Status Epilepticus in Kainic Acid-induced Model of Temporal Lobe Epilepsy by Targeting Apoptosis and Astrogliosis

392

Hepatocyte growth factor in gingival crevicular fluid and the distribution of hepatocyte growth factor-activator in gingival tissue from adult periodontitis

393

Hepatocyte growth factor in human amniotic fluid promotes the migration of fetal small intestinal epithelial cells, ,

394

Hepatocyte growth factor induces activation of Nck and phospholipase C-γ in lung carcinoma cells

395

Hepatocyte growth factor induces collagenase (matrix metalloproteinase-1) via the transcription factor Ets-1 in human hepatic stellate cell line

396

Hepatocyte growth factor inhibits insulin-stimulated glycogen synthesis in primary cultured hepatocytes

397

Hepatocyte growth factor is a survival factor for endothelial cells and is expressed in human atherosclerotic plaques

398

Hepatocyte growth factor level in the vitreou of patient with proliferative vitreoretinopathy

399

Hepatocyte growth factor plays roles in the induction and autocrine maintenance of bone marrow stromal cell IL-11, SDF-1α, and stem cell factor

400

Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis

401

Hepatocyte growth factor protects cardiac myocytes against oxidative stress-induced apoptosis

402

Hepatocyte Growth Factor Regulation of Uterine Epithelial Cell Transepithelial Resistance and Tumor Necrosis Factor (alpha)Release in Culture

403

Hepatocyte growth factor/scatter factor in development, inflammation and carcinogenesis: its expression and role in oral tissues

404

Hepatocyte growth factor/scatter factor, angiogenesis and tumour cell proliferation in primary breast cancer

405

Hepatocyte growth factor: a multifunctional cytokine

406

Hepatocyte growth factor-induced proliferation of hepatic stem-like cells depends on activation of NF-κB

407

Hepatocyte IKKβ/NF-κB Inhibits Tumor Promotion and Progression by Preventing Oxidative Stress-Driven STAT3 Activation

408

Hepatocyte Isolation From Unused/Rejected Livers for Transplantation: Initial Step Toward Hepatocyte Transplantation, the First Experience From Iran

409

Hepatocyte Necrosis Induced by Oxidative Stress and IL-1α Release Mediate Carcinogen-Induced Compensatory Proliferation and Liver Tumorigenesis

410

Hepatocyte nuclear factor (HNF)-4α/γ, HNF-1α, and vHNF-1 regulate the cell-specific expression of the human dihydrodiol dehydrogenase (DD)4/AKR1C4 gene

411

Hepatocyte Nuclear Factor 1 α Controls Renal Expression of the Npt1-Npt4 Anionic Transporter Locus

412

Hepatocyte Nuclear Factor 4 Alpha Ligand Binding and F Domains Mediate Interaction and Transcriptional Synergy with the Pancreatic Islet LIM HD Transcription Factor Isl1

413

Hepatocyte Nuclear Factor 4 Is a Transcription Factor that Constitutively Binds Fatty Acids

414

Hepatocyte Nuclear Factor 4-Mediated Activation of Rat CYP3A1 Gene and Its Modes of Modulation by Apolipoprotein AI Regulatory Protein I and v-ErbA-Related Protein 3

415

Hepatocyte nuclear factor-4α plays pivotal roles in the regulation of mouse carboxylesterase 2 gene transcription in mouse liver

416

Hepatocyte performance on different crystallographic faces of rutile

417

Hepatocyte Polyploidy and Metabolism/Life-history Traits: Hypotheses Testing

418

Hepatocyte proliferation – can we target the mechanism?

419

Hepatocyte proliferation and serum hepatocyte growth factor levels in patients with alcoholic hepatitis

420

Hepatocyte proliferation in primary biliary cirrhosis as assessed by proliferating cell nuclear antigen and Ki-67 antigen labelling

421

Hepatocyte proliferative activity in human liver cirrhosis

422

Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3

423

Hepatocyte transplantation as a treatment for glycogen storage disease type 1a

424

Hepatocyte transplantation: emerging insights into mechanisms of liver repopulation and their relevance to potential therapies

425

Hepatocyte vacuolation and autolytic changes in the liver of pilot whales, Globicephala melas, stranded on Cape Cod, MA, USA

426

Hepatocyte-Derived MicroRNAS as Serum Predictors of Rejection of Liver Transplantation

427

Hepatocytes as a source of collagen type XVIII endostatin

428

Hepatocyte-stimulated expression of hepatocyte growth factor (HGF) in cultured rat hepatic stellate cells

429

Hepatocyte-supported serum-free culture of rat liver sinusoidal endothelial cells

430

Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature

431

Hepatoid carcinoma of the pancreas mimicking neuroendocrine tumor

432

Hepatoid Variant of Yolk Sac Tumor of Both Ovaries With Widespread Intraabdominal and Lung Metastasis: A Case Report

433

Hepatologie : Edited by Gerok/Blum, 942, Urban & Schwarzenberg, US $ 398, ISBN 3-541-12272-2

434

Hepatology may have problems with putative surrogate outcome measures

435

Hepatoma-derived Growth Factor Represses SET and MYND Domain Containing 1 Gene Expression through Interaction with C-terminal Binding Protein

436

Hepatomegaly: A Major Clinical Sign in Some Metabolic Disorders

437

Hepatopancreas mitochondria of Mytilus galloprovincialis: effect of zinc ions on mitochondrial bioenergetics and metabolism

438

Hepatopancreatic nuclease of black tiger shrimp Penaeus monodon unlikely to be involved in viral triggered apoptosis

439

Hepatopathy and Reno-cardiopathy Induced by Ritalin in Rats

440

Hepatoprotection of sesquiterpenoids: A quantitative structure–activity relationship (QSAR) approach

441

Hepatoprotection of tea seed oil (Camellia oleifera Abel.) against CCl4-induced oxidative damage in rats

442

Hepatoprotective Activity of “Orthosiphon stamineus” on Liver Damage Caused by Paracetamol in Rats

443

Hepatoprotective activity of aerial parts of Otostegia persica against carbon tetrachloride-induced liver damage in rats

444

Hepatoprotective activity of Amaranthus spinosus in experimental animals

445

Hepatoprotective activity of Andrographis Paniculata and Swertia Chirayita

446

Hepatoprotective Activity of Camellia Sinensis and Its Possible Mechanism of Action

447

Hepatoprotective Activity of Capparis spinosa Root Bark Against CCl4 Induced Hepatic Damage in Mice

448

Hepatoprotective Activity of Caspian Saffron (Crocus caspius Fisch and Mey) Flowers against CCl4 Induced Acute Liver Injury in Mice

449

Hepatoprotective Activity of Cichorium intybus L. Leaves Extract Against Carbon Tetrachloride Induced Toxicity

450

Hepatoprotective activity of colocasia antiquorum against experimentally induced liver injury in rats

451

Hepatoprotective Activity of Cucumis trigonus Roxb. Fruit against CCl4 Inducesd Hepatic Damage in Rats

452

HEPATOPROTECTIVE ACTIVITY OF Iphiona grantioides AND Pluchea arguta FOR ACETAMINOPHEN INDUCED TOXICITY IN RABBITS

453

Hepatoprotective activity of Mammea africana ethanol stem bark extract

454

Hepatoprotective Activity of Momordica diocia Roxb Fruits in CCl4-Induced Hepatotoxicity in Rats

455

Hepatoprotective activity of phloretin and hydroxychalcones against Acetaminophen Induced hepatotoxicity in mice

456

HEPATOPROTECTIVE ACTIVITY OF PHYLLANTHUS RETICULATUS

457

Hepatoprotective activity of puerarin against carbon tetrachloride-induced injuries in rats: A randomized controlled trial

458

Hepatoprotective activity of royal jelly on mercuric chloride–induced damage model in rats

459

Hepatoprotective activity of Schouwia thebica webb

460

Hepatoprotective activity of the ethanol extract of Curcuma heyneana rhizome on isoniazid and rifampin-induced liver injury rats

461

Hepatoprotective Activity of the Ethanolic Extract of Ficus carica Linn. Leaves in Carbon Tetrachloride-Induced Hepatotoxicity in Rats

462

Hepatoprotective activity of the extract of Homalium letestui stem against paracetamol-induced liver injury

463

Hepatoprotective activity of the total flavonoids from Rosa laevigata Michx fruit in mice treated by paracetamol

464

Hepatoprotective amide constituents from the fruit of Piper chaba: Structural requirements, mode of action, and new amides Original Research Article

465

Hepatoprotective and antifibrotic effects of trans-chalcone against bile duct ligation-induced liver fibrosis in rats

466

Hepatoprotective and antiobesity effects of mirabegron, a novel β3-adrenoceptor agonist, on carbon tetrachloride-induced hepatotoxicity in obese rats

467

Hepatoprotective and Antioxidant Activities of Combination of Cinnamomum zeylanicum and Zingiber officinale in CCl4intoxicated Rats

468

Hepatoprotective and antioxidant activity of ethanolic extracts of edible lotus (Nelumbo nucifera Gaertn.) leaves

469

Hepatoprotective and Antioxidant Activity of Euphorbia tirucalli

470

Hepatoprotective and antioxidant effects of Azolla microphylla based gold nanoparticles against acetaminophen induced toxicity in a fresh water common carp fish (Cyprinus carpio L.)

471

Hepatoprotective and antioxidant effects of Bupleurum kaoi Liu (Chao et Chuang) extract and its fractions fractionated using supercritical CO2 on CCl4-induced liver damage

472

Hepatoprotective and antioxidant effects of Commiphora berryi (Arn) Engl bark extract against CCl4-induced oxidative damage in rats

473

Hepatoprotective and Antioxidant Effects of Eupatorium ayapana against Carbon Tetrachloride Induced Hepatotoxicity in Rats

474

Hepatoprotective and antioxidant effects of lycopene in acute cholestasis

475

Hepatoprotective and Anti-oxidant effects of Nepeta Ispahanica Boiss extract on CCL4 induced liver Injury

476

Hepatoprotective and antioxidant effects of porcine plasma protein hydrolysates on carbon tetrachloride-induced liver damage in rats

477

Hepatoprotective and antioxidant effects of the coffee diterpenes kahweol and cafestol on carbon tetrachloride-induced liver damage in mice

478

Hepatoprotective and antioxidant polyphenols from a standardized methanolic extract of the leaves of Liquidambar styraciflua L.

479

Hepatoprotective and antioxidative effects of total phenolics from Laggera pterodonta on chemical-induced injury in primary cultured neonatal rat hepatocytes

480

Hepatoprotective and Hypolipidemic Effects of Carthamus tinctorius oil in Alloxan-induced Type 1 Diabetic Rats

481

Hepatoprotective and Hypolipidemic Effects of Satureja Khuzestanica Essential Oil in Alloxan-induced Type 1 Diabetic Rats

482

Hepatoprotective and hypolipidemic effects of water-soluble polysaccharidic extract of Pleurotus eryngii

483

Hepatoprotective and nitric oxide production inhibitory activities of coumarin and polyacetylene constituents from the roots of Angelica furcijuga

484

Hepatoprotective constituents from Zedoariae Rhizoma: absolute stereostructures of three new carabrane-type sesquiterpenes, curcumenolactones A, B, and C Original Research Article

485

Hepatoprotective effect and antioxidant role of sun, sulphited-dried apricot (Prunus armeniaca L.) and its kernel against ethanol-induced oxidative stress in rats

486

Hepatoprotective effect and mechanistic insights of deoxyelephantopin, a phyto-sesquiterpene lactone, against fulminant hepatitis

487

Hepatoprotective Effect of 17β-Estradiol as Antioxidant Modulators Against Stress Damage

488

Hepatoprotective effect of 2,3-dehydrosilybin on carbon tetrachloride-induced liver injury in rats

489

Hepatoprotective effect of Acantholimon bracteatum (Girard) Boiss. on formaldehyde-induced liver injury in adult male mice

490

Hepatoprotective Effect of Adenema hyssopifolium G. Don (Gentianaceae) in Carbon Tetrachloride-Induced Hepatotoxicity in Rats

491

Hepatoprotective Effect of Allium hooshidaryae Hydroalcoholic Extract on Acetaminophen-Induced Hepatotoxicity in Male Rats

492

Hepatoprotective Effect of Alpha Lipoic Acid Against Bromobenzene-Induced Liver Damage in Rats

493

Hepatoprotective Effect of an Indian Salt Marsh Herb Suaeda Monoica Forsk. Ex. Gmel Against Concanavalin-A Induced Toxicity in Rats

494

Hepatoprotective Effect of Aqueous Extract of Persian Gulf Brown Algae Sargassum swartzii Against Acetaminophen-Induced Hepatotoxicity in Mice

495

HEPATOPROTECTIVE EFFECT OF CARNOSINE ON LIVER BIOCHEMICAL PARAMETERS IN CHRONIC ETHANOL INTOXICATED RAT

496

Hepatoprotective effect of chitooligosaccharides against tert-butylhydroperoxide-induced damage in Chang liver cells

497

Hepatoprotective Effect of Coenzyme Q10 in Rats with Diclofenac Toxicity

498

Hepatoprotective Effect of Cornus mas Fruits Extract Against Carbon Tetrachloride-Induced Hepatic Damage in Male Albino Rats

499

Hepatoprotective effect of Crocus sativus (saffron) petals extract against acetaminophen toxicity in male Wistar rats

500

Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice

501

Hepatoprotective effect of Descurainia sophia seed extract against paracetamol-induced oxidative stress and hepatic damage in mice

502

Hepatoprotective effect of electrolyzed reduced water against carbon tetrachloride-induced liver damage in mice

503

Hepatoprotective Effect of Ethanolic Extract of Lavandula officinalis L. in Alloxan-Induced Diabetic Rats

504

hepatoprotective effect of ethanolic extract of lavandula officinalis l.in alloxan-induced diabetic rats

505

Hepatoprotective Effect of Ficus carica Leaf Extract on Mice Intoxicated with Carbon Tetrachloride

506

HEPATOPROTECTIVE EFFECT OF GARLIC (ALLIUM SATIVUM) AND MILK THISTLE (SILYMARIN) IN ISONIAZID INDUCED HEPATOTOXICITY IN RATS

507

Hepatoprotective Effect of Glycyrrhiza Glabra in Carbon Tetrachloride-Induced Model of Acute Liver Injury

508

Hepatoprotective effect of herbal drug on CCl4 induced liver damage

509

Hepatoprotective effect of kaempferol glycosides isolated from Cedrela odorata L. leaves in albino mice: involvement of Raf/MAPK pathway

510

Hepatoprotective Effect of Lactobacillus Plantarum Against Salmonella Typhimurium in Mice

511

Hepatoprotective Effect of Matricaria chamomilla Hot Aqueous Extract Against Methomyl 90%- Induced Hepatotoxicity In Mice

512

Hepatoprotective Effect of Microemulsion-Based System of Prunus Cerasus Kernel Extract on CCL₄-induced Liver Damage in Mice

513

HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE

514

HEPATOPROTECTIVE EFFECT OF MORUS ALBA L. IN CARBON TETRACHLORIDE- INDUCED HEPATOTOXICITY IN MICE

515

Hepatoprotective effect of mulberry water extracts on ethanol-induced liver injury via anti-inflammation and inhibition of lipogenesis in C57BL/6J mice

516

Hepatoprotective Effect of Otostegia persica Boiss. Shoot Extract on Carbon Tetrachloride-Induced Acute Liver Damage in Rats

517

Hepatoprotective effect of polyphenols rich methanolic extract of Amorphophallus commutatus var. wayanadensis against CCl4 induced hepatic injury in swiss albino mice

518

Hepatoprotective Effect of Pomegranate (Punica Granatum) Fruit Juice and Seed Extracts against CCL4-Induced Toxicity

519

Hepatoprotective effect of Rosa canina fruit extract against carbon tetrachloride induced hepatotoxicity in rat

520

Hepatoprotective effect of Rosmarinus officinalis and rosmarinic acid on acetaminophen-induced liver damage

521

Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect

522

Hepatoprotective Effect of Satureja Khuzestanica Essential Oil and Vitamin E in Experimental Hyperthyroid Rats: Evidence for Role of Antioxidant Effect

523

Hepatoprotective effect of silyamarin in individuals chronically exposed to hydrogen sulfide; modulating influence of TNF-α cytokine genetic polymorphism

524

Hepatoprotective Effect of Silymarin and Propolis in Chemically Induced Chronic Liver Injury in Rats

525

Hepatoprotective effect of the root extract of Decalepis hamiltonii against carbon tetrachloride-induced oxidative stress in rats

526

Hepatoprotective effect of the root extract of green tea against malathion-induced oxidative stress in rats

527

hepatoprotective effect of vitamin b12 in acetaminophen induce hepatotoxicity in male rats

528

Hepatoprotective effect of vitamins C and E against gasoline vapor-induced liver injury in male rats

529

Hepatoprotective Effect of Zizyphus vulgaris on Carbon Tetrachloride (CCl4) Induced Liver Damage in Rats as Animal Model

530

Hepatoprotective effect of β-myrcene pretreatment against acetaminophen-induced liver injury

531

Hepatoprotective Effects of a Novel Trihoney against Nonalcoholic Fatty Liver Disease: A Comparative Study with Atorvastatin

532

Hepatoprotective effects of almond oil against carbon tetrachloride induced liver injury in rats

533

Hepatoprotective Effects of Arbutin against Liver Damage Induced by Carbon Tetrachloride in Rats

534

Hepatoprotective effects of Artemia salina L. extract against carbon tetrachloride-induced toxicity

535

Hepatoprotective Effects of Avicennia marina (Forssk.) Vierh.

536

HEPATOPROTECTIVE EFFECTS OF BERBERIS LYCIUM, GALIUM APARINE AND PISTACIA INTEGERRIMA IN CARBON TETRACHLORIDE (CCL4)-TREATED RATS

537

Hepatoprotective effects of betaine on liver damages followed by myocardial infarction

538

Hepatoprotective Effects of Biochanin A Against Acetaminophen-Induced Liver Toxicity in Mice

539

Hepatoprotective Effects of Black Pomegranate (Punica granatum L.) Peel Extract on Tert-Butyl Hydroperoxide Induced Oxidative Stress in Rats

540

Hepatoprotective effects of chestnut (Castanea crenata) inner shell extract against chronic ethanol-induced oxidative stress in C57BL/6 mice

541

Hepatoprotective Effects of Chitosan and Chitosan Nanoparticles against Biochemical, Genetic, and Histological Disorders Induced by the Toxicity of Emamectin Benzoate

542

Hepatoprotective Effects of Coenzyme Q10 against Amoxiclav-induced Hepatotoxicity in the Rat Model

543

Hepatoprotective Effects of Combination Hydroalcoholic Extracts of Nigella Sativa and Curcuma Longa on Adriamycin- Induced Oxidative Stress in Rat

544

Hepatoprotective effects of dieckol-rich phlorotannins from Ecklonia cava, a brown seaweed, against ethanol induced liver damage in BALB/c mice

545

Hepatoprotective effects of eburicoic acid and dehydroeburicoic acid from Antrodia camphorata in a mouse model of acute hepatic injury

546

Hepatoprotective Effects of Ethanol Extract of Caesalpiniabonduc against Carbon Tetrachloride Induced Hepatotoxicity in Albino Rats

547

Hepatoprotective effects of fermented Curcuma longa L. on carbon tetrachloride-induced oxidative stress in rats

548

Hepatoprotective effects of fermented field water-dropwort (Oenanthe javanica) extract and its major constituents

549

Hepatoprotective effects of Gentiana asclepiadea L. extracts against carbon tetrachloride induced liver injury in rats

550

Hepatoprotective effects of Gentisic acid through its anti-oxidant properties in nicotinamide-streptozotocin induced diabetic mice

551

Hepatoprotective effects of glycyrrhizin and omega-3 fatty acids on Nuclear Factor-kappa B pathway in thioacetamide-induced fibrosis in rats

552

Hepatoprotective Effects of Hertia cheirifolia Butanolic Extract and Selenium against CCl4 -induced Toxicity in Rats

553

Hepatoprotective effects of hydroethanolic extracts of Crocus sativus tepals, stigmas and leaves on carbon tetrachloride induced acute liver injury in rats

554

Hepatoprotective effects of licochalcone B on carbon tetrachloride-induced liver toxicity in mice

555

Hepatoprotective effects of Lycium chinense Miller fruit and its constituent betaine in CCl4-induced hepatic damage in rats

556

Hepatoprotective effects of Malva sylvestris L. against paracetamol-induced hepatotoxicity

557

Hepatoprotective Effects of Opuntia dillenii Haw Fruit in a Mice Model of Lung Cancer

558

Hepatoprotective Effects of Pentoxifylline against Acrolein-Induced Mitochondrial Dysfunction in Rat Liver

559

Hepatoprotective effects of Platycodon grandiflorum on acetaminophen-induced liver damage in mice

560

Hepatoprotective Effects of Propolis Extract: A Biochemical and Histopathological Approach

561

Hepatoprotective effects of purified oleuropein from olive leaf extract against ethanol-induced damages in the rat

562

Hepatoprotective Effects of Silymarin on Liver Injury via Irisin Upregulation and Oxidative Stress Reduction in Rats with Type 2 Diabetes

563

Hepatoprotective Effects of Taraxacum officinale Root Extract on Permethrin-induced Liver Toxicity in Adult Mice

564

Hepatoprotective effects of total saponins isolated from Taraphochlamys affinis against carbon tetrachloride induced liver injury in rats

565

Hepatoprotective efficacy of Grewia asiatica fruit against oxidative stress in swiss albino mice

566

Hepatoprotective Evaluation of Butea monosperma against Liver damage by Paracetamol in Rabbits

567

Hepatoprotective glycosides from Leonurus japonicus Houtt. Original Research Article

568

Hepatoprotective Herbs, Avicenna Viewpoint

569

Hepatoprotective mechanism of schisandrin B: role of mitochondrial glutathione antioxidant status and heat shock proteins

570

Hepatoprotective potential and antioxidant activity of Allium tripedale in acetaminophen-induced oxidative damage

571

Hepatoprotective potential of polyphenol rich extract of Murraya koenigii L.: An in vivo study

572

Hepatoprotective Potential of Prosopis farcta Beans Extracts against Acetaminophen-induced Hepatotoxicity in Wister Rats

573

Hepatoprotective potential of Saraca ashoka (Roxb.) De Wilde bark by carbon tetrachloride induced liver damage in rats

574

Hepatoprotective potentials of Phyllanthus amarus against ethanol-induced oxidative stress in rats

575

Hepatoprotective principles from the flowers of Tilia argentea (Linden): structure requirements of tiliroside and mechanisms of action Original Research Article

576

Hepatoprotective Properties of Cuminum cyminum Seeds Powder as Post-Treatment for Acetaminophen-Induced Injury

577

Hepatoprotective properties of p-coumaric acid in a rat model of ischemiareperfusion

578

Hepatoprotective properties of sesamin against CCl4 induced oxidative stress-mediated apoptosis in mice via JNK pathway

579

Hepatoprotective properties of the glycolipoprotein extract from Eisenia foetida

580

Hepatoprotective pyrrole derivatives of Lycium chinense fruits

581

Hepatoprotective role and antioxidant capacity of pomegranate (Punica granatum) flowers infusion against trichloroacetic acid-exposed in rats

582

Hepatoprotective Role of Milk Thistle (Silybum marianum) in Meat Type Chicken Fed Aflatoxin B1 Contaminated Feed

583

HEPATOPROTECTIVE STUDIES ON HALOXYLON SALICORNICUM: A PLANT FROM CHOLISTAN DESERT

584

Hepatoprotective, anti-inflammatory and antioxidant activities of Flacourtia montana J. Grah leaf extract in male Wistar rats

585

Hepatoprotective, superoxide scavenging, and antioxidative activities of aromatic constituents from the bark of Betula platyphylla var. japonica

586

Hepatoprotetive, Cardioprotective and Nephroprotective Actions of Essential Oil Extract of Artemisia sieberi in Alloxan Induced Diabetic Rats

587

Hepatopulmonary Syndrome and Post-Liver Transplantation Complications: A Case-Control Study

588

Hepatopulmonary syndrome associated with Budd-Chiari syndrome

589

Hepatopulmonary syndrome associated with cardiorespiratory disease

590

Hepatopulmonary syndrome in candidates for liver transplantation

591

Hepatopulmonary syndrome in patients with Schistosoma mansoni periportal fibrosis

592

Hepatopulmonary syndrome in transplant centres at different altitudes

593

Hepatopulmonary Syndrome with Right-to-left Shunt in Cirrhotic Patients Using Macro-Aggregated Albumin Lung Perfusion Scan: Comparison with Contrast Echocardiography and Association with Clinical Data

594

Hepatopulmonary syndrome: Angiography and therapeutic embolization

595

Hepato-pulmonary syndrome: successful treatment by transjugular intrahepatic portosystemic stent-shunt (TIPS)

596

Hepatorenal and genotoxic effects of genetically modified quail meat in a 90-day dietary toxicity study in mice

597

Hepatorenal and Testicular Functions Concomitant with Induced Hypo and Hyperprolactinemia in Male Rats

598

Hepato-Renal Dysfunctions Induced by Gold Nanoparticles and Preservative Efficacy of Black Seed Oil

599

Hepatorenal effect of prolonged low-flow sevoflurane anesthesia on patients with renal impairment

600

Hepatorenal Protective Effects of Sesame Seeds Oil, Flaxseed Oil and their Mixture against Methotrexate Toxicity in Rats

601

Hepatorenal syndrome

602

Hepatorenal syndrome: Response to terlipressin and albumin and its determinants

603

Hepatorenal-toxicities Accompanying Exposure to Indoor Air Pollutants in Chemical Storekeepers at an International Market

604

Hepatoselectivity of statins: Design and synthesis of 4-sulfamoyl pyrroles as HMG-CoA reductase inhibitors

605

Hepatosplenic Candidiasis Detected by ^18F-FDG-PET/CT

606

Hepatosplenic Gamma Delta T-Cell Lymphoma (HSGDTCL): Two Rare Case Reports from Western India

607

Hepato-Splenic gamma sigma T-Cell Lymphoma: A Rare Entity Mimicking the Hemophagocytic Syndrome

608

HEPATOSPLENIC MORBIDITY IN SCHISTOSOMIASIS JAPONICA: EVALUATION WITH DOPPLER SONOGRAPHY

609

Hepatosplenic Mucor Balls

610

Hepatosplenic T Cell Lymphoma: Diagnostic Conundrum

611

Hepatosplenic γδ T cell lymphoma: a diagnostic pitfall

612

Hepatosplenomegalic lipidosis: what unless Gaucher? Adult cholesteryl ester storage disease (CESD) with anemia, mesenteric lipodystrophy, increased plasma chitotriosidase activity and a homozygous lysosomal acid lipase −1 exon 8 splice junction mutation

613

Hepatotoxic and Nephrotoxic Effects of Kerosene on Female Wistar Rats: a Comparison of Two Routes of Exposure

614

Hepatotoxic Effect of Hydrogen Cyanamide (Dormex®) in Albino Rats and the Ameliorative Effect of Melatonin

615

HEPATOTOXIC EFFECT OF NICKEL SULPHATE ON MICE

616

Hepatotoxic effects of mycotoxin combinations in mice

617

Hepatotoxic microcystin diversity in cyanobacterial blooms collected in portuguese freshwaters

618

Hepatotoxicity After Exposure to Tebuconazole: A Case Report and Brief Review

619

Hepatotoxicity Among Poisoned Patients: A Cross-sectional Study

620

Hepatotoxicity and consequently increased cell proliferation are associated with flumequine hepatocarcinogenesis in mice

621

Hepatotoxicity and genotoxicity of patulin in mice, and its modulation by green tea polyphenols administration

622

Hepatotoxicity and nephrotoxicity of 3-bromopyruvate in mice

623

HEPATOTOXICITY ASSOCIATED WITH HYPOGLYCEMIC EFFECTS OF TEUCRIUM POLIUM IN DIABETIC RATS

624

Hepatotoxicity associated with the ingestion of Papaver Rhoease

625

Hepatotoxicity due to a formulation of Ganoderma lucidum (lingzhi)

626

Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): A growing concern

627

Hepatotoxicity Due To Mushroom Poisoning: A Case Report

628

Hepatotoxicity from first line antiretroviral therapy: an experience from a resource limited setting

629

Hepatotoxicity in Both Occupationally and Environmentally-Exposed Inhabitants of a Lead-Zinc Mining Community

630

Hepatotoxicity in drug development: detection, significance and solutions

631

Hepatotoxicity in sheep and goats caused by experimental feeding with foxtail millet (Setariaitalica)

632

Hepatotoxicity Induced by Azole Antifungal Agents: A Review Study

633

Hepatotoxicity induced by iron overload and alcohol : Studies on the role of chelatable iron, cytochrome P450 2E1 and lipid peroxidation

634

Hepatotoxicity of androstenedione in pregnant rats

635

Hepatotoxicity of Antiretroviral Drugs in HIV Seropositive Nigerian Patients

636

Hepatotoxicity of antiretrovirals: Incidence, mechanisms and management

637

HEPATOTOXICITY OF CARBON TETRACHLORIDE: PROTECTIVE EFFECT OF GONGRONEMA LATIFOLIUM

638

Hepatotoxicity of Dorema Aucheri (Bilhar) in Albino Mice

639

Hepatotoxicity of Halogenated Inhalational Anesthetics

640

Hepatotoxicity of herbal remedies

641

Hepatotoxicity of high oral dose (−)-epigallocatechin-3-gallate in mice

642

Hepatotoxicity of monobromobenzene and hexabromobenzene: effects of repeated dosage in rats

643

Hepatotoxicity of non-narcotic analgesics

644

Hepatotoxicity of Nonsteroidal Anti-Inflammatory Drugs: A Systematic Review of Randomized Controlled Trials

645

Hepatotoxicity of Polyethylene Glycol and Possible Protection Using Moringa Oleifera Leaves Extract (MOLE)

646

Hepatotoxicity of polyunsaturated fatty acids in alcohol abuser

647

Hepatotoxicity of tubers of Indian Kudzu (Pueraria tuberosa) in rats

648

Hepatotropic conjugate of adenine arabinoside monophosphate with lactosaminated poly- -lysine : Synthesis of the carrier and pharmacological properties of the conjugate

649

Hepatotropism of GB virus C (GBV-C): GBV-C replication in human hepatocytes and cells of human hepatoma cell lines

650

Hepato-vagal pathway associated with nicotineʹs anorectic effect in the rat

651

Hepatozoon species infections in Nigeria

652

He–Pb double dating of detrital zircons from the Ganges and Indus Rivers: Implication for quantifying sediment recycling and provenance studies

653

Hepcidin and anaemia

654

Hepcidin and HFE Polymorphisms and Ferritin Level in β-Thalassemia Major

655

Hepcidin and iron-related gene expression in subjects with Dysmetabolic Hepatic Iron Overload

656

Hepcidin and regulation of iron homeostasis in maintenance hemodialysis patients

657

Hepcidin Gene Cloning and Expression Pattern in Turbot (Scophthalmus maximus) after Vibrio. anguillarum Infection

658

Hepcidin gene expression induced in the developmental stages of fish upon exposure to Benzo[a]pyrene (BaP)

659

Hepcidin generated by hepatoma cells inhibits iron export from co-cultured THP1 monocytes

660

Hepcidin in hemodialysis patients and its association with anemia and serum iron indices

661

Hepcidin in the management of patients with mild non-hemochromatotic iron overload: Fact or fiction?

662

Hepcidin Induces M1 Macrophage Polarization in Monocytes or THP-1 Derived Macrophages

663

Hepcidin is a friend rather than a foe in COVID19-induced complications

664

Hepcidin mimetics from microorganisms? A possible explanation for the effect of Helicobacter pylori on iron homeostasis

665

Hepcidin, A New Iron Regulatory Peptide

666

Hepcidin, interleukin-6 and hematological iron markers in males before and after heart surgery

667

Hepcidin: A multitask molecule in fish

668

Hepcidin—a regulator of intestinal iron absorption and iron recycling by macrophages

669

HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium

670

HEPHESTUS: An expert system in PROLOG for the interpretation of the pyrolysis-mass spectra of polyesters, polyethers and polyureas using the certainty factor model

671

HEPI: A new tool for human error probability calculation for offshore operation

672

HepML, an XML-based format for describing simulated data in high energy physics Original Research Article

673

HEPN1, a novel gene that is frequently down-regulated in hepatocellular carcinoma, suppresses cell growth and induces apoptosis in HepG2 cells

674

HEP-NET OPINION ABOUT THE MANAGEMENT OF PATIENTS WITH CHRONIC HEPATITIS C IN PAKISTAN IN THE ERA OF AVAILABLE DIRECT ACTING ANTIVIRALS

675

Hepsin promotes prostate cancer progression and metastasis

676

Hept-1-yne partial hydrogenation reaction over supported Pd and W catalysts Original Research Article

677

Heptacoordinate dithiophosphate Mo(II) and W(II) complexes: molecular structures of mono and binuclear phosphine complexes

678

Heptacoordinate dithiophosphate W(II) and Mo(II) complexes of diphosphines and iodide

679

Heptacoordinate tricarbonyl Mo(II) complexes as highly selective oxidation homogeneous and heterogeneous catalysts

680

Heptacoordinated diphenyllead; hexa- and pentacoordinated triphenyllead and tin compounds derived from 5H-benzimidazo[1,2-c]quinazoline-6-thione

681

Heptacyclo[6.6.0.02,6.03,13.04,11.05,9.010,14]tetradecane: a new type of spacer for mediating electron transfer processes

682

Heptadecafluorooctanesulfonic acid (C8F17SO3H) catalyzed intramolecular hydroamination of olefinic sulfonamides in fluorous biphase system (FBS)

683

Heptadecanols from the leaves of Persea americana var. americana

684

Heptadentate Schiff-base based PVC membrane sensor for Fe(III) ion determination in water samples

685

Heptahelical receptor signaling in heart failure

686

Heptakis(2,3-di-O-carboxymethyl)-(beta)-cyclodextrin as a pH-sensitive Host

687

Heptakis(6-deoxy-6-guanidino)-β-cyclodextrin: an artificial model for mitochondrial ADP/ATP carrier

688

Heptakis[6-S-(2,3-dihydroxypropyl)-6-thio] cyclomaltoheptaose and its sulfone: water-soluble β-cyclodextrin derivatives having modified polarity

689

Heptakis-6-(5-methylene-thioureido-5′-methyl-2,2′-bipyridyl)-β-cyclodextrin: synthesis and metal complexation study

690

Heptakis-6-(5-methylene-ureido-5′-methyl-2,2′-bithiazolyl)-cyclomaltoheptaose as a new fluorescent polydentate ligand

691

Heptane isomerization over molybdenum oxides obtained by H2 reduction of HxMoO3 with different hydrogen contents Original Research Article

692

Heptane Reforming over Pt–Re/Al2O3: Reaction Network, Kinetics, and Apparent Selective Catalyst Deactivation

693

Heptanuclear and Decanuclear Manganese Complexes with the Anion of 2-Hydroxymethylpyridine

694

Heptanuclear cobalt(II) dicubane compounds with single-molecule magnet behavior

695

Heptaphyrins: Expanded porphyrins with seven heterocyclic rings

696

Heptyl oleate synthesis as useful tool to discriminate between lipases, proteases and other hydrolases in crude preparations

697

698

Her 2 Overexpression in Breast Carcinoma; Its Significance and Association with Age and Tumor Grade

699

Her Majesty’s coroners and Home Office forensic pathologists perception of the nurses’ role in the coroner’s enquiry

700

701

Her story of cognitive science

702

HER2 aberrations in cancer: Implications for therapy

703

HER2 and proliferation of wound-induced breast carcinoma

704

HER2 and proliferation of wound-induced breast carcinoma

705

HER2 and proliferation of wound-induced breast carcinoma

706

HER2 and surgery: more questions to answer

707

HER2 discordance between primary and metastatic breast cancer: Assessing the clinical impact

708

HER-2 DNA quantification of paraffin-embedded breast carcinomas with LightCycler real-time PCR in comparison to immunohistochemistry and chromogenic in situ hybridization

709

HER2 expression in Brazilian patients with estrogen and progesterone receptor-negative breast carcinoma

710

HER-2 gene amplification by chromogenic in situ hybridisation (CISH) compared with fluorescence in situ hybridisation (FISH) in breast cancer—A study of two hundred cases

711

HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer

712

HER2 kinase domain mutation results in constitutive phosphorylation and activation of HER2 and EGFR and resistance to EGFR tyrosine kinase inhibitors

713

HER2 Overexpression in Borderline and Malignant Ovarian Tumors: A Cross-sectional Study in an Iranian Population and Literature Review

714

HER2 overexpression-mediated inflammatory signaling enhances mammosphere formation through up-regulation of aryl hydrocarbon receptor transcription

715

HER2 Protein Overexpression in Infiltrating Ductal Carcinoma of the Breast Associated with Lymph Node Involvement

716

HER-2 Protein Overexpression in Patients with Gastric and Oesophageal Adenocarcinoma at a Tertiary Care Facility in Ghana

717

HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer

718

HER2 status and UPA/PAI-1 provide complementary information on patient outcome in node-negative breast cancer

719

HER2 status in advanced breast cancer: which option for aromatase inhibitors?

720

HER2 Testing in Invasive Breast Cancer: A Comparison Between Immunohistochemistry and Fluorescence In Situ Hybridization Assays

721

HER2 testing: Current status and future directions

722

HER2/HER3 heterodimers in prostate cancer: Whither HER1/EGFR?

723

HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia

724

HER2/neu expression in bladder cancer: relationship to cell cycle kinetics

725

Her-2/Neu Expression in Bladder Urothelial Carcinoma

726

HER-2/neu Expression in Resectable Gastric Cancer and its Relationship with Histopathologic Subtype, Grade, and Stage

727

Her2/neu Expression in Wilmsʹʹ Tumor and Correlation With Histopathologic Findings

728

HER2/neu kinase-dependent modulation of androgen receptor function through effects on DNA binding and stability

729

HER-2/neu Marker Examination using Immunohistochemical Method in Patients Suffering from Gastric Adenocarcinoma

730

HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features

731

HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features

732

HER-2/neu Overxpression in Esophageal Squamous Cell Carcinoma (ESCC) and Its Correlation with Patient’s Clinicopathological Features

733

Her-2/Neu, Estrogen and Progesterone Receptor Expression In WHO Grade I Meningiomas

734

HER2/neu: A Prognostic Marker for Ovarian Carcinoma

735

HER-2-mediated endocytosis of magnetic nanospheres and the implications in cell targeting and particle magnetization

736

HER2-mediated upregulation of MMP-1 is involved in gastric cancer cell invasion

737

HER2-Positive Breast Cancer: Tumor-to-Liver SUV Ratio is the Best Parameter for Detection in F-18 FDG-PET/CT

738

Her2-specific Multivalent Adapters Confer Designed Tropism to Adenovirus for Gene Targeting

739

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

740

HER2-targeted therapy in breast cancer: A systematic review of neoadjuvant trials

741

HER-3 Knocking Down Induces G2/M Arrest in Gastric Cancer Cells

742

HER4 rs1595065 3ʹUTR Variant is a Possible Risk Factor for HER2 Positivity Among Breast Cancer Patients

743

HERA and the asymptotic behaviour of F2p

744

HERA anomaly and hard charm in the nucleon

745

HERA collider physics

746

HERA data and DGLAP evolution: Theory and phenomenology

747

HERA events, tevatron jets, and uncertainties on quarks at large x

748

HERA prospects on compositeness and new vector bosons

749

HERA results on electroweak interactions at high momentum transfers

750

HERA results on the structure of the proton

751

HERA today, gone tomorrow?

752

HERA-3 Original Research Article

753

HERA-B data acquisition system

754

HERA-B data acquisition system

755

HERA-B framework for online calibration and alignment

756

HERA-B framework for online calibration and alignment

757

HERA-B higher-level triggers: architecture and software

758

HERA-B higher-level triggers: architecture and software

759

760

761

HERA-B RICH light collection system

762

HERA-B RICH light collection system

763

HERA-B RICH: Performance and physics impact

764

HERA-B RICH: Performance and physics impact

765

766

767

HERA-B triggering

768

HERA-B, an experiment to study CP violation at the HERA proton ring using an internal target

769

HERA-B: overview and 1996 engineering run

770

HERA-B: overview and 1996 engineering run

771

HERA-B: overview and engineering runs

772

HERA-B: overview and engineering runs

773

HERA-B: physics potential and prospects

774

HERA-B: physics potential and prospects

775

HERA-B: status and commissioning results

776

HERA-B: status and commissioning results

777

HERA-B: trigger system

778

HERA-B: trigger system

779

HERACLES-II setup at TRIUMF

780

HERACLES-II setup at TRIUMF

781

HERA-data in the light of small x evolution with state of the art NLO input

782

Heraeus acquires BASFʹs business in ceramic & glassware colorants

783

Herakles’in On İki İşi Betimli Mozaik Hakkında Tespitler

784

Heralded two-photon entanglement from probabilistic quantum logic operations on multiple parametric down-conversion sources

785

Herb and vitamin upplementation ue among a general ophthalmology practice population

786

Herb digoxin interactions

787

Herb gallwasp Neaylax salviae (Giraud, 1859) (Hymenoptera, Aylacini) – new record from Turkey

788

Herb layer extinction debt in highly fragmented temperate forests – Completely paid after 160 years?

789

Herb medicine Inchin-ko-to (TJ-135) regulates PDGF-BB-dependent signaling pathways of hepatic stellate cells in primary culture and attenuates development of liver fibrosis induced by thioacetamide administration in rats

790

Herb Target Prediction Using Machine Learning Methods in a Heterogeneous Network

791

Herbaceous biomass retrieval in habitats of complex composition: a model merging SAR images with unmixed Tlandsat TM data

792

Herbaceous energy crops: A general survey and a microeconomic analysis

793

Herbaceous layer response to 17 years of controlled deer hunting in forested natural areas

794

Herbaceous plant biomass harvest and delivery cost with harvest segmented by month and number of harvest machines endogenously determined

795

Herbaceous vegetation response to grazing exclusion in patches and inter-patches in semi-arid pasture and woody encroachment

796

Herbacetin induces apoptosis in HepG2 cells: Involvements of ROS and PI3K/Akt pathway

797

Herbage and Animal Responses to Management Intensity of Continuously Stocked Bahiagrass Pastures

798

Herbage and Seed Production of Two Species of Lathyrus L. under Rainfed Condition of Borujerd, Iran

799

Herbage biomass production and nutritive value of mulberry (Morus alba) and Calliandra calothyrsus harvested at different cutting frequencies

800

Herbage intake and milk yield of dairy cows grazing perennial ryegrass swards or white clover/perennial ryegrass swards at low- and medium-herbage allowances

801

HERBAGE MINERAL NUTRITION INDEXED AS TOOLS FOR RAPID MINERAL STATUS DIAGNOSIS IN TROPICAL PASTURES

802

Herbage production and chemical characteristics for bioenergy production by plant functional groups from semi-natural grasslands

803

Herbage yield in Signalgrass pastures as affected by grazing management

804

Herbage yield of Persian clover (Trifolium resupinatum L.) as affected by row distance and herbicide application

805

Herbal agents and over-the-counter medications in pregnancy

806

Herbal and Conventional Toothpastes Roles in Gingivitis Control in Orthodontic Patients

807

Herbal and Dietary Supplement–Drug Interactions in Patients Taking Digoxin

808

Herbal and nutritional supplement use among college students in Qatar

809

Herbal Appetizer for Children with Failure to Thrive (FTT) in View of Traditional Persian Medicine: A Review

810

HERBAL APPROACHES FOR EPILEPSY: A REVIEW

811

Herbal Cosmeceuticals for Photoprotection from Ultraviolet B Radiation: A Review

812

Herbal cosmeceuticals: New opportunities in cosmetology

813

Herbal Diet and the Impact of Nutrition on Lipogenic Activity, a System Biology Study

814

Herbal does not mean innocuous: Ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife® products

815

Herbal Drugs with Promising Anti-Leishmanial Activity: New Hope for Leishmaniasis Treatment

816

Herbal Extract Decolourization Device Using Activated Carbon

817

Herbal extracts and essential oils microencapsulation studies for different applications

818

Herbal Fertility Remedies Leading to Massive Pulmonary Embolism: A Case Report

819

Herbal formula CGX ameliorates LPS/d-galactosamine-induced hepatitis

820

Herbal hepatotoxicity by Greater Celandine (Chelidonium majus): Causality assessment of 22 spontaneous reports

821

Herbal infusions bioelectrochemical polyphenolic index: Green tea – The gallic acid interference

822

Herbal infusions; their phenolic profile, antioxidant and anti-inflammatory effects in HT29 and PC3 cells

823

HERBAL INTAKE: UNDIAGNOSED HYPOTHYROIDISM LEADING TO POSTOPERATIVE REFRACTORY CIRCULATORY COLLAPSE - A Case Report -

824

Herbal Medications to Manage Insomnia: An Overview of Clinical Trials using Herbal Treatment for Insomnia

825

Herbal Medicinal Products from Passiflora for Anxiety: An Unexploited Potential

826

Herbal Medicinal Products, Medpharm, Stuttgart, Germany, F. Gaedcke, B. Steinhoff, H. Blasius (Eds.). CRC Press, Boca Raton, USA (2003)

827

Herbal medicine analysis by liquid chromatography/time-of-flight mass spectrometry

828

Herbal medicine and liver disease, for any conclusion we need to do more studies

829

Herbal Medicine and Sexual Behavior in Diabetic Patients

830

Herbal Medicine and Vaginal Candidiasis in Iran: A Review

831

Herbal Medicine and Vaginal Candidiasis in Iran: A Review

832

Herbal Medicine as Inducers of Apoptosis in Cancer Treatment

833

Herbal Medicine as Neuroprotective Potential Agent in Human and Animal Models: A Historical Overview

834

Herbal medicine heads for the mainstream

835

Herbal Medicine in the Treatment of Premenstrual Syndromes

836

Herbal Medicine in Treatment of Recurrent Aphthous Stomatitis: A Literature Review

837

Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet

838

Herbal Medicine Isolation, Phaleria macrocarpa for primary glioblastoma multiforme cells

839

Herbal medicine Sho-saiko-to (TJ-9) prevent liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient -amino acid-defined diet

840

Herbal medicine under scrutiny

841

Herbal Medicine, Second Edition.: Rudolf Fritz Wiess, MD and Volker Fintelmann, MD. ISBN 0-86577-970-8, Thieme, NY, 438 pp.

842

Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects

843

Herbal Medicines and Epilepsy: To the Editor

844

Herbal Medicines and Other Traditional Remedies in Iran – A Tragedy Unfolds

845

Herbal Medicines and Reactivation of Chronic Hepatitis B Virus Infection

846

Herbal Medicines for Immunosuppression

847

Herbal Medicines in Diabetes

848

Herbal Medicines In The Treatment of Psychiatric and Neurological Disorders

849

Herbal Medicines Used in Kidney Diseases in Europe

850

Herbal Medicines Used in Treatment of Nonalcoholic Fatty Liver Disease: A Mini-Review

851

Herbal medicines: a new hope for autism therapy

852

Herbal Medicines: from Traditional Medicine to Modern Experimental Approaches

853

Herbal medicines—primum non nocere

854

Herbal Nanoemulsion in Topical Drug Delivery and Skin Disorders: Green Approach

855

Herbal nano-ointment containing encapsulated polysaccharide in repairing of superficial ulcers

856

Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review

857

Herbal prevention and treatment of nipple trauma and/or pain in Iranian studies: a systematic review

858

Herbal Products in Cesarean Wound Healing

859

Herbal Products in the Care and Prevention of Breast Fissure in Lactating Women: A Systematic Review

860

Herbal Products Review Provides Inaccurate Information on Dietary Supplement Regulations

861

Herbal Products Review: What Do We Really Know?

862

Herbal Products Use During Pregnancy in North of Iran

863

Herbal remedies and medicine; introducing some Iranian plants

864

Herbal Remedies CD-ROM, T. Brendler, J. Gruenwald, C. Jaenicke (Eds.). Medpharm GmbH Scientific Publishers, Stuttgart Germany (2003)

865

Herbal Remedies Connected to Malaria like Fever in Iranian Ancient Medicinal Books- Brief Review Article.

866

Herbal Remedies Effective on Treating Idiopathic Pulmonary Fibrosis

867

Herbal Remedies for Acne Vulgaris from the Viewpoint of Persian Medicine

868

Herbal Remedies for Cancer based on Persian Medicine

869

Herbal Remedies for Functional Dyspepsia and Traditional Iranian Medicine Perspective

870

Herbal remedies for oligomenorrhea in Traditional Persian Medicine

871

Herbal Remedies for Pediatric Earache in Traditional Iranian Medicine

872

Herbal remedies—how safe are they? A case report of polymorphic ventricular tachycardia/ventricular fibrillation induced by herbal medication used for obesity

873

Herbal Research: Gaps Affecting the Quality and Validity of Research Findings

874

HERBAL RMIDIES USED FOR GASTROINTESTINAL DISORDERS IN KAGHAN VALLEY, NWFP, PAKISTAN

875

Herbal self-medication use in patients with diabetes mellitus type 2

876

Herbal Supplement Use and Herb–drug Interactions among Patients with Kidney Disease

877

Herbal supplementation diets on hematology and innate immunity in goldfish against Aeromonas hydrophila

878

Herbal Therapy and Treatment of Worm Infections, Emphasizing Taenia solium

879

Herbal Therapy for Burn Wound Infections

880

Herbal therapy in Covid-19: A systematic review of medicinal plants effective against Covid-19

881

Herbal therapy in opioid withdrawal syndrome: A systematic review of randomized clinical trials

882

HERBAL TREATMENT FOR CARDIOVASCULAR DISEASE THE EVIDENCE BASED THERAPY

883

Herbal Treatment of Hypertension: A Literature Review

884

Herbal Treatment of Oligomenorrhea with Sesamum indicum L.: A Randomized Controlled Trial

885

Herbal treatment options for female fertility disorders: a systematic review of clinical trials

886

Herbal Treatments for Asthma, according to Avicenna

887

Herbal Treatments to Gain Weight as the Potential Cause of Portal Vein Thrombosis and Hepatic Damage: A Case Report

888

Herbal Whitening Agents: Traditional Remedies for Reducing Tooth Discoloration

889

Herbal, Animal and Mineral Remedies in Burn Wound: a review of Persian Traditional Medicine literature

890

Herbal-caffeinated chewing gum, but not bubble gum, improves aspects of memory

891

Herbals in cardiovascular practice: Are physicians neglecting anything?

892

Herbarium images launched

893

Herbarium specimens demonstrate earlier flowering times in response to warming in Boston

894

Herb–drug interaction of Fucus vesiculosus extract and amiodarone in rats: A potential risk for reduced bioavailability of amiodarone in clinical practice

895

Herb-drug interactions

896

Herb-drug interactions

897

Herb–drug interactions: Effect of Ginkgo biloba extract on the pharmacokinetics of theophylline in rats

898

Herbert Blankenhorn in the Third Reich

899

900

Herbert D. Kelleher, Southwest Airlines, 2003 Bower Award for Business Leadership laureate

901

Herbert Holik (Ed.), Handbook of paper and board, Wiley-VCH, Weinheim, Germany, 2006 (xix+505, £105-00, ISBN: 3-527-30997-7)

902

Herbert Robbins and sequential analysis

903

Herbert screw fixation of capitellar fractures

904

Herbert Simon and behavioral economics

905

Herbert Simon and the concept of dispersed entrepreneurship

906

Herbert Simon. Artificial intelligence as a framework for understanding intuition

907

Herbicidal activity of allelopathic extracts of sorghum and some herbicides on wheat and accompanied weeds

908

Herbicidal activity of constituents isolated from Solanum elaeagnifolium (Solanaceae)

909

HERBICIDAL ACTIVITY OF Datura metel L. AGAINST Phalaris minor Retz

910

Herbicidal activity of eight isothiocyanates on Texas panicum (Panicum texanum), large crabgrass (Digitaria sanguinalis), and sicklepod (Sennaobtusifolia)

911

Herbicidal Activity of Mycelial and Cell Free Extracts of Fusarium oxysporum F.sp. Ciceris Against Rice Weed Cyperus Iria l

912

HERBICIDAL ACTIVITY OF SOME MEDICINAL PLANTS EXTRACTS AGAINST Parthenium hysterophorus L.

913

Herbicidal and antioxidant responses of transgenic rice overexpressing Myxococcus xanthus protoporphyrinogen oxidase

914

HERBICIDAL CONTROL OF Lantana camara

915

HERBICIDAL EFFECT OF FICUS BENGALENSIS AQUEOUS EXTRACT ON IPOMOEA PENTAPHYLLA

916

Herbicidal effects under field conditions of Ailanthus altissima bark extract, which contains ailanthone

917

Herbicidal ionic liquid with dual-function

918

Herbicidal potential of Azadirachta indica leaves extract against Achyranthes aspera and Senna occidentalis

919

Herbicidal, Insecticidal and Structure-Activity Relationship Studies on Pyranopyrazole and Oxinobispyrazole Derivatives

920

Herbicide accumulation and evolution in reservoir sediments Original Research Article

921

Herbicide and insect resistant elite transgenic rice

922

Herbicide and metabolite movement in different soils as studied by computer assisted microlysimeters

923

Herbicide and plant growth regulator analysis by capillary electrophoresis

924

Herbicide concentrations in the Mississippi River Basin—the importance of chloroacetanilide herbicide degradates

925

Herbicide contamination and dispersion pattern in lowland springs Original Research Article

926

Herbicide contamination and the potential impact to seagrass meadows in Hervey Bay, Queensland, Australia

927

HERBICIDE CONTAMINATION IN CARROT GROWN IN PUNJAB, PAKISTAN

928

Herbicide contamination of surficial groundwater in Northern Italy

929

Herbicide dissipation and dynamics modelling in three different tillage systems

930

Herbicide distribution in soils of a riparian forest and neighboring sugar cane field

931

Herbicide dose and incorporation depth in combination with 1,3- dichloropropene plus chloropicrin for Cyperus rotundus control in tomato and pepper

932

Herbicide drift can affect plant and arthropod communities

933

Herbicide effect on growth and seed production of Lolium multiflorum in Atlantic Canada

934

Herbicide effects on typha latifolia (Linneaus) germination and root and shoot development

935

Herbicide evaluation for the control of wild taro

936

Herbicide impact on Hormosira banksii gametes measured by fluorescence and germination bioassays

937

Herbicide Isoproturon-Specific Binding in the Freshwater Macrophyte Elodea densa-A Single-Cell Fluorescence Study

938

Herbicide loss in surface runoff from a pastoral hillslope in the Pukemanga catchment (New Zealand): Role of pre-event soil water content

939

Herbicide losses in runoff events from a field with a low slope: Role of a vegetative filter strip

940

Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants CoExpressing Human CYP1A1, CYP2B6, and CYP2C19

941

Herbicide Metabolism and Cross-Tolerance in Transgenic Potato Plants Expressing Human CYP1A1

942

Herbicide Metabolism and Tolerance in the Transgenic Rice Plants Expressing Human CYP2C9 and CYP2C19

943

Herbicide Residues in Water Resources: A Scoping Review

944

Herbicide Resistance and Supersensitivity in Ala250 or Ala251 Mutants of the D1 Protein in Chlamydomonas reinhardtii,

945

Herbicide resistance dynamics in a spatially heterogeneous environment

946

HERBICIDE RESISTANCE IN ANNUAL RYEGRASS (Lolium rigidum Gaud.) POPULATIONS IN WHEAT FIELDS OF FIROOZABAD IRAN

947

Herbicide Retention in Soil as Affected by Sugarcane Mulch Residue

948

Herbicide risk assessment for non-target aquatic plants: sulfosulfuron - a case study

949

Herbicide safeners: uses, limitations, metabolism, and mechanisms of action

950

Herbicide Selectivity applied in post-emergence of Mulato II grass

951

Herbicide sensitivity of Echinochloa spp. accessions in Italian rice fields

952

Herbicide sorption, degradation, and leaching in three Swedish soils under long-term conventional and reduced tillage

953

Herbicide tolerance in maize is related to increased levels of glutathione and glutathione-associated enzymes

954

Herbicide toxicity of Halophila ovalis assessed by chlorophyll a fluorescence

955

Herbicide transport by surface runoff and herbicide retention in a filter strip — Rainfall and runoff simulation studies

956

Herbicide transport via surface runoff during intermittent artificial rainfall: A laboratory plot scale study

957

Herbicide/Pesticide Effects on Intestinal Epithelial Growth,

958

Herbicides affect fluorescence and electron transfer activity of spinach chloroplasts, thylakoid membranes and isolated Photosystem II

959

Herbicides and herbicide degradates in shallow groundwater and the Cedar River near a municipal well field, Cedar Rapids, Iowa

960

Herbicides and Herbicide Degradation Products in Upper Midwest Agricultural Streams during August BaseFlow Conditions

961

Herbicides and nitrogen in precipitation: progression from west to east and contribution to the Marne river (France)

962

HERBICIDES AND THEIR DOSES EFFECTS ON WILD ONION (Asphodelus tenuifolius Cav.) IN CHICKPEA

963

Herbicides and their mechanisms of action. Sheffield Biological Sciences, Volume 6. Edited by Andrew Cobb and Ralph Kirkwood. 2000.

964

Herbicides and Transformation Products in Surface Waters of the Midwestern United States

965

Herbicides for control of isoproturon-resistant Littleseed Canarygrass (Phalaris minor) in wheat

966

Herbicides for control of metsulfuron resistant toothed dock (Rumex dentatus)

967

Herbicides genotoxicity

968

Herbicides genotoxicity

969

Herbicides have negligible effects on ants and springtails in an Australian wheat field

970

Herbicides have negligible effects on ants and springtails in an Australian wheat field

971

Herbicides implicated as the cause of severe mangrove dieback in the Mackay region, NE Australia: consequences for marine plant habitats of the GBR World Heritage Area

972

HERBICIDES, THEIR APPLICATION TIMINGS AND DIFFERENT SOIL TEMPERATURE REGIMES AFFECT WEED INFESTATION IN WHEAT

973

Herbicides, weeds and endangered species: management of bitou bush (Chrysanthemoides monilifera ssp. rotundata) with glyphosate and impacts on the endangered shrub, Pimelea spicata Original Research Article

974

Herbicide-tolerant sugarcane (Saccharum officinarum L.) plants: an unconventional method of weed removal

975

Herbivore and pollinator responses to grassland management intensity along experimental changes in plant species richness

976

Herbivore diet selection in response to simulated variation in nutrient rewards and plant secondary compounds

977

Herbivore host choice and optimal bad motherhood

978

Herbivore species and density affect vegetation-structure patchiness in salt marshes

979

Herbivore-associated elicitors: FAC signaling and metabolism

980

Herbivore-associated elicitors: FAC signaling and metabolism

981

Herbivore-induced coexistence of competing plant species

982

Herbivore-Induced Defense Response in a Model Legume. Two-Spotted Spider Mites Induce Emission of (E)-(beta)Ocimene and Transcript Accumulation of (E)-(beta)-Ocimene Synthase in Lotus japonicus

983

Herbivores alter the fitness benefits of a plant–rhizobium mutualism

984

Herbivores Coprolites from Chehrabad Salt Mine of Zanjan, Iran (Sassanid Era, 224-651 AD) Reveals Eggs of Strongylidae and Anoplocephalidae Helminths

985

Herbivores enable plant survival under nutrient limited conditions in a model grazing system

986

Herbivores enable plant survival under nutrient limited conditions in a model grazing system

987

Herbivores, the Functional Diversity of Plants Species, and the Cycling of Nutrients in Ecosystems

988

Herbivorous and microbial grazing pathways of metazooplankton in the Senegal River Estuary (West Africa)

989

Herbivory alters competitive interactions between two invasive aquatic plants

990

Herbivory alters the expression of a mixed-mating system

991

Herbivory and seedling performance in a fragmented temperate forest of Chile

992

Herbivory at marginal populations: Consequences for maternal fitness and vegetative differentiation

993

Herbivory by the pine weevil (Hylobius abietis L.) and short-snouted weevils (Strophosoma melanogrammum Forst. and Otiorhynchus scaber L.) during the conversion of a wind-thrown Norway spruce forest into a mixedspecies plantation

994

Herbivory by the weevil, Strophosoma melanogrammum, causes severalfold increase in emission of monoterpenes from young Norway spruce (Picea abies)

995

HERBIVORY COULD UNLOCK MUTATIONS SEQUESTERED IN STRATIFIED SHOOT APICES OF GENETIC MOSAICS

996

Herbivory in a Mediterranean forest: browsing impact and plant compensation

997

Herbivory in early Tertiary Arctic forests

998

Herbivory on macro-algae affects colonization of beach-cast algal wrack by detritivores but not its decomposition

999

Herbivory passing the limits

1000

Herbivory responsive C2H2 zinc finger transcription factor protein StZFP2 from potato

بازگشت